申请人:Syntex (U.S.A.) Inc.
公开号:US04792570A1
公开(公告)日:1988-12-20
Compounds useful for treating inflammation, swelling and associated pain, represented by the formula: ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein: a is an integer of 0-3; b is an integer of 0-2; n is an integer of 3-12; each X and each Y are independently -halo, --R.sup.1, -alkoxy, or -phenyl; and B is selected from the group consisting of: --NR.sup.1 R.sup.2, --NR.sup.1 (CH.sub.2 CH.sub.2 OH), ##STR2## in which R.sup.1 and R.sup.2 are independently H, alkyl or cycloalkyl; R.sup.3 is H, alkyl or --CH.sub.2 CH.sub.2 OH; and m is an integer of 3-8. Novel compounds are those wherein n is at least 6 if both a and b are 0.
该公式代表用于治疗炎症、肿胀和相关疼痛的化合物,其表示为:##STR1##及其药学上可接受的酸盐,其中:a为0-3的整数;b为0-2的整数;n为3-12的整数;每个X和每个Y都是独立的-halo、-R1、-alkoxy或-phenyl;B选自以下组:--NR1R2、--NR1(CH2CH2OH)、##STR2## 其中R1和R2是独立的H、烷基或环烷基;R3是H、烷基或--CH2CH2OH;m为3-8的整数。当a和b都为0时,新的化合物中n至少为6。